BCL6 and B-cell non-Hodgkin lymphoma: Between 15 and 20 months of age, 36–62% of BCL6-overexpressing mice had developed B-cell lymphoma (compared to 2–8% in wild-type mice), and 75% of these cases resembled DLBCL.